Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

Wang, K., Du, R., Myall, N. J., Lewis, W. E., Uy, N., Hong, L., Skoulidis, F., Byers, L. A., Tsao, A., Cascone, T., Pozadzides, J., Tu, J., Negrao, M. V., Gibbons, D. L., Park, K., Rinsurongkawong, W., Lee, J. J., Gandara, D., Behl, D., … Le, X. (2024). Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC. Journal of Thoracic Oncology, 19(3), 500–506. https://doi.org/10.1016/j.jtho.2023.11.020
Authors:
Kaiwen Wang
Robyn Du
Nathaniel J. Myall
Whitney E. Lewis
Natalie Uy
Lingzhi Hong
Ferdinandos Skoulidis
Lauren A. Byers
Anne S. Tsao
Tina Cascone
Jenny Vu Pozadzides
Janet Tu
Marcelo V. Negrão
Don L. Gibbons
Keunchil Park
Waree Rinsurongkawong
John Lee
David R. Gandara
Deepti Behl
Catherine A. Shu
Jonathan W. Riess
Christina S. Baik
Heather A. Wakelee
Ara A. Vaporciyan
John V. Heymach
Jianjun Zhang
Xiuning Le
Affiliated Authors:
Catherine A. Shu
Subjects:
Lung Neoplasms (MeSH)
Antineoplastic Agents (MeSH)
Carcinoma, Non-Small-Cell Lung (MeSH)
Acrylamides (MeSH)
Indoles (MeSH)
Pyrimidines (MeSH)
Antibodies, Bispecific (MeSH)
Advancements in Lung Cancer Research (OpenAlex Topic)
Genomic Landscape of Cancer and Mutational Signatures (OpenAlex Topic)
Small Cell Lung Cancer (OpenAlex Topic)
Author Keywords:
real-world analysis
amivantamab
egfr
nsclc
elink
Publication Type:
Article
Unique ID:
10.1016/j.jtho.2023.11.020
PMID:
38012986
DOI:
10.1016/j.jtho.2023.11.020
Journal:
Journal of Thoracic Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: